Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TARO | Taro Pharmaceutical Industries Ltd.

IndexRUT P/E67.35 EPS (ttm)0.57 Insider Own36.60% Shs Outstand37.59M Perf Week0.84%
Market Cap1.44B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.09M Perf Month3.23%
Income21.40M PEG- EPS next Q0.18 Inst Own12.50% Short Float / Ratio4.93% / 6.34 Perf Quarter0.05%
Sales575.20M P/S2.49 EPS this Y-56.30% Inst Trans0.49% Short Interest0.40M Perf Half Y53.28%
Book/sh46.26 P/B0.83 EPS next Y- ROA1.00% Target Price- Perf Year26.18%
Cash/sh21.52 P/C1.78 EPS next 5Y-12.95% ROE1.20% 52W Range22.89 - 42.22 Perf YTD31.96%
Dividend- P/FCF34.83 EPS past 5Y-33.70% ROI0.30% 52W High-9.24% Beta0.60
Dividend %- Quick Ratio2.80 Sales past 5Y-2.80% Gross Margin43.60% 52W Low67.41% ATR0.84
Employees1554 Current Ratio3.40 Sales Q/Q1.40% Oper. Margin-0.70% RSI (14)51.60 Volatility2.18% 2.35%
OptionableYes Debt/Eq0.00 EPS Q/Q-28.70% Profit Margin3.70% Rel Volume0.28 Prev Close38.86
ShortableYes LT Debt/Eq0.00 EarningsJul 27 BMO Payout0.00% Avg Volume62.92K Price38.32
Recom2.00 SMA20-0.67% SMA502.08% SMA20018.98% Volume17,848 Change-1.39%
Date Action Analyst Rating Change Price Target Change
Jul-27-20Reiterated H.C. Wainwright Buy $96 → $82
Feb-04-20Reiterated H.C. Wainwright Buy $110 → $94
Nov-05-19Reiterated H.C. Wainwright Buy $105 → $110
Mar-12-18Initiated H.C. Wainwright Buy $124
May-23-17Downgrade Credit Suisse Outperform → Neutral
Jul-27-23 05:32AM
Jul-26-23 08:36PM
Jul-19-23 04:00PM
Jun-30-23 09:00AM
12:25PM Loading…
May-30-23 12:25PM
May-23-23 07:28PM
May-18-23 04:46PM
Apr-17-23 01:35PM
Jan-27-23 06:01AM
Jan-24-23 05:43PM
Jan-19-23 05:02PM
Oct-27-22 07:55PM
12:37PM Loading…
Oct-24-22 12:37PM
Oct-12-22 10:58AM
Aug-11-22 06:17PM
Jul-27-22 07:05PM
Jul-26-22 04:10PM
Jul-06-22 06:10AM
May-26-22 07:00PM
May-23-22 05:35PM
May-20-22 07:00PM
May-17-22 08:15AM
May-16-22 09:05AM
May-13-22 09:55AM
May-12-22 08:15AM
10:29AM Loading…
May-05-22 10:29AM
May-04-22 08:45AM
Feb-28-22 06:19PM
Feb-22-22 09:23AM
Jan-27-22 07:15PM
Jan-25-22 08:11AM
Jan-20-22 08:45PM
Jan-19-22 03:01PM
Jan-05-22 07:48AM
Dec-01-21 05:05PM
Nov-15-21 12:15PM
Oct-28-21 06:45PM
Oct-27-21 11:18AM
Oct-21-21 01:01PM
Oct-20-21 03:03PM
Jul-29-21 07:44AM
Jul-27-21 08:45PM
Jul-20-21 09:05PM
Jul-19-21 06:49AM
Jul-14-21 05:54PM
Jun-18-21 10:00AM
May-19-21 05:30PM
May-12-21 05:58PM
Mar-09-21 05:37AM
Jan-27-21 05:46PM
Jan-20-21 08:28PM
Dec-12-20 07:48PM
Oct-29-20 06:00AM
Oct-28-20 06:45PM
Oct-21-20 06:44PM
Sep-28-20 01:01PM
Sep-10-20 03:19PM
Jul-29-20 06:55PM
Jul-23-20 04:32PM
Jul-22-20 02:37PM
Jun-25-20 06:45PM
Jun-19-20 09:30AM
May-29-20 05:41PM
May-20-20 06:00AM
May-19-20 06:45PM
May-12-20 07:37PM
May-06-20 10:09AM
Apr-06-20 12:26PM
Mar-27-20 10:46AM
Mar-22-20 10:35AM
Mar-04-20 04:33PM
Feb-20-20 05:54PM
Feb-05-20 12:45PM
Feb-03-20 06:35PM
Jan-28-20 06:19PM
Jan-16-20 12:44PM
Jan-10-20 03:00PM
Dec-19-19 06:27PM
Dec-17-19 09:23PM
Dec-16-19 03:55PM
Dec-06-19 08:45AM
Nov-29-19 08:39AM
Nov-22-19 12:03AM
Nov-15-19 08:00AM
Nov-04-19 08:15PM
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.